Hepatocellular carcinoma in cirrhosis: incidence and risk factors

G Fattovich, T Stroffolini, I Zagni, F Donato - Gastroenterology, 2004 - Elsevier
Emerging data indicate that the mortality rate of hepatocellular carcinoma (HCC) associated
with cirrhosis is rising in some developed countries, whereas mortality from non-HCC …

Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis

M Sherman - Seminars in liver disease, 2010 - thieme-connect.com
Hepatocellular carcinoma (HCC) is increasing in incidence in many countries, and is the
most common cause of death in patients with cirrhosis. With regular surveillance, small early …

[图书][B] WHO classification of tumours of the digestive system.

FT Bosman, F Carneiro, RH Hruban, ND Theise - 2010 - cabidigitallibrary.org
This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference

J Bruix, M Sherman, JM Llovet… - Journal of …, 2001 - journal-of-hepatology.eu
Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is increasing
worldwide, but striking geographical differences are observed for both risk factors and …

Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status

F Trevisani, PE D'Intino, AM Morselli-Labate… - Journal of …, 2001 - Elsevier
Background: It is not established whether virological status affects the efficiency of α-
fetoprotein (AFP) as a hepatocellular carcinoma (HCC) marker among patients with chronic …

Simplified staging for hepatocellular carcinoma

JN Vauthey, GY Lauwers, NF Esnaola… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: The current American Joint Committee on Cancer (AJCC) staging system for
hepatocellular carcinoma (HCC) fails to stratify patients adequately with respect to …

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

L Bolondi, S Sofia, S Siringo, S Gaiani, A Casali… - Gut, 2001 - gut.bmj.com
BACKGROUND Hepatocellular carcinoma (HCC) is a major cause of death in cirrhotic
patients. This neoplasm is associated with liver cirrhosis (LC) in more than 90% of cases …

[PDF][PDF] Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

International Consensus Group for Hepatocellular … - …, 2009 - Wiley Online Library
Materials and Methods Twenty-six resected cases of nodules from 23 patients with chronic
hepatitis or cirrhosis caused by hepatitis B or Abbreviations: GPC3, glypican-3; GS …

Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms

BN Nguyen, JF Fléjou, B Terris, J Belghiti… - The American journal …, 1999 - journals.lww.com
Atypical histologic variants of focal nodular hyperplasia have been reported and are
sometimes difficult to recognize. To characterize the morphologic spectrum of focal nodular …

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

RF Velázquez, M Rodrı́guez, CA Navascués, A Linares… - Hepatology, 2003 - Elsevier
Better knowledge of the risk factors associated with the appearance of hepatocellular
carcinoma (HCC) could improve the efficacy of surveillance programs. A total of 463 patients …